ResearchRSSYesterday
A study in Japan found that Hemlibra, a medicine used to treat acquired hemophilia A (a rare bleeding disorder that develops later in life), appears to be safe when used alongside other medications that suppress the immune system. Acquired hemophilia A is different from the hemophilia people are born with—it happens when the body mistakenly attacks its own clotting proteins. This is the first real-world evidence supporting Hemlibra's safety for this condition in actual patients.
WHY IT MATTERSIf you have acquired hemophilia A in Japan or are considering treatment options, this study suggests Hemlibra may be a safe addition to your treatment plan, though you should discuss this with your hematologist to see if it's right for your specific situation.
ResearchRSSMay 12
A new study from Germany found that people with hemophilia who have advanced joint damage walk differently than others, mainly because their ankles don't move as well. To adapt to this limited ankle movement, their bodies develop new walking patterns that may use more energy and be less efficient. Understanding these changes could help doctors better support hemophilia patients in staying active.
WHY IT MATTERSIf you have hemophilia with joint damage, knowing that your altered walking pattern is a direct result of reduced ankle mobility could help you work with your doctor on targeted physical therapy or mobility interventions to improve efficiency and reduce fatigue.
ResearchRSSMay 1
A new study found that many women who carry hemophilia gene mutations are not getting proper medical care, even though they live in countries with good healthcare systems. These women often don't know they carry the mutation and aren't included in official patient lists. The main problem is that they can't easily access genetic testing to find out if they have the mutation.
WHY IT MATTERSWomen with hemophilia mutations may experience bleeding problems and need specialized care, but without diagnosis and medical attention, they won't know to seek treatment or get proper support for their health.
ResearchRSSApr 22
A new study shows that regular exercise — including activities like walking, strength training, and balance work — is safe and helpful for people with hemophilia of all ages. The research found that exercise can reduce chronic pain, improve how well people can move and function, and make life better overall. The key is that exercise programs need to be carefully designed for each person's needs.
WHY IT MATTERSPeople with hemophilia often avoid exercise due to bleeding concerns, but this study provides evidence that structured exercise can safely reduce pain and improve daily functioning without increasing bleeding risk.
ResearchRSSApr 22
Researchers developed an artificial intelligence tool that can accurately detect bleeding inside joints in adults with hemophilia by analyzing ultrasound images. This technology could eventually allow patients to get ultrasound scans at home instead of traveling to a hospital or clinic. Early detection of joint bleeding is important because it helps prevent long-term damage to the joints.
WHY IT MATTERSHemophilia patients currently must travel to medical facilities for ultrasound imaging to detect joint bleeds; this AI tool could enable home-based monitoring, reducing travel burden and potentially catching bleeding episodes earlier.
ResearchPUBMEDApr 22
Researchers in Germany studied health insurance records from 2017-2019 to understand how hemophilia A (a bleeding disorder) affects patients and how much it costs to treat. They found 257 patients with hemophilia A and grouped them by severity—mild, moderate, or severe—based on how much clotting medicine they needed. This study shows that insurance data can help doctors and researchers learn more about rare diseases like hemophilia A.
WHY IT MATTERSIf you have hemophilia A in Germany, this research demonstrates that your health insurance claims data can be used to better understand disease patterns, treatment costs, and care gaps—potentially leading to improved healthcare planning and resource allocation for your condition.